The purpose of randomization in clinical trials is to ensure that there are no systematic differences between treatment groups with respect to measured and unmeasured baseline characteristics that could influence the outcome of interest.1 In a randomized clinical trial (RCT) without selection or information bias, an unadjusted analysis (ie, an analysis that does not take baseline characteristics into account) will provide unbiased estimates of treatment effects.
Sign in to take quiz and track your certificates
JN Learning™ is the home for CME and MOC from the JAMA Network. Search by specialty or US state and earn AMA PRA Category 1 Credit(s)™ from articles, audio, Clinical Challenges and more. Learn more about CME/MOC
CME Disclosure Statement: Unless noted, all individuals in control of content reported no relevant financial relationships. If applicable, all relevant financial relationships have been mitigated.
Corresponding Author: Lars W. Andersen, MD, MPH, PhD, DMSc, Department of Anesthesiology and Intensive Care, Aarhus University Hospital, Nørrebrogade 44, Aarhus, NA 8000, Denmark (firstname.lastname@example.org).
Published Online: November 17, 2022. doi:10.1001/jama.2022.21506
Conflict of Interest Disclosures: None reported.
Disclaimer: Dr Anderson is a statistical reviewer for JAMA but was not involved in any of the decisions regarding review of the manuscript or its acceptance.
You currently have no searches saved.
You currently have no courses saved.